Search - tctmd.com

Displaying 561 - 580 of 619

Sort: Relevancy | Date

News Daily News

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Yael L. Maxwell

May 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

Presentation

2016 TCTMD Heart Team Survey

Presenter: 190204|Yael L. Maxwell

April 13, 2016

News Features

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Yael L. Maxwell

March 30, 2016

News Daily News

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

Michael O'Riordan

March 01, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News Stories for 2015

Shelley Wood

December 29, 2015

News Opinion Editor's Corner

Las 10 Noticias de TCTMD Más Leídas de 2015

Shelley Wood

December 29, 2015

News Daily News

Senate Votes to Repeal Medical Device Tax, Though Presidential Veto Likely

Yael L. Maxwell

December 08, 2015

News Daily News

El Senado de EE.UU. Aprueba la Derogación del Impuesto sobre Dispositivos Médicos, que Posiblemente será Vetada por el Presidente

Yael L. Maxwell

December 08, 2015

News Daily News

MVARC文件提供了二尖瓣治疗研究的模板

Todd Neale

July 16, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

Todd Neale

July 16, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

June 22, 2015

Advertisement

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

TCTMD’s Top 10 Most Popular Stories for April 2016

2016 TCTMD Heart Team Survey

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

TCTMD’s Top 10 Most Popular News Stories for 2015

Las 10 Noticias de TCTMD Más Leídas de 2015

Senate Votes to Repeal Medical Device Tax, Though Presidential Veto Likely

El Senado de EE.UU. Aprueba la Derogación del Impuesto sobre Dispositivos Médicos, que Posiblemente será Vetada por el Presidente

MVARC文件提供了二尖瓣治疗研究的模板

MVARC Document Offers Template for Mitral Valve Therapeutics Research

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content